PureCycle Technologies, Inc. Q2 FY2025 earnings call

• Shift towards growth with successful capital raise in late June and global growth plans in Asia, Europe, and the U.S., aiming for ~1 billion pounds of installed capacity by 2030.
• Commercial progress with 17 customer applications in post-trial discussions, and first major commercial agreement with Emerald for approximately 5 million pounds of purified resin starting in Q3.
• Successful film trial achieved earlier than expected, with plans for additional large-scale trials in August and September.
• Ironton facility had onstream times approaching 90% in April and May, produced pellets for 65 consecutive days, and successfully ran at 14,000 pounds per hour rate test.
• Initiated compounding expansion at Ironton to increase on-site compounding capacity to approximately 100 million pounds, expected to realize cost savings in excess of $4 million per year and payback in less than 2 years.

No detailed breakdown of product segment financials with revenue contribution % provided in the transcript.

• Anticipate revenue ramp in Q3 and Q4, with Q3 expected to have higher revenue than Q2, aiming for $4 million per month revenue in Q3.
• Corporate EBITDA breakeven target still on track for the Q4 to Q1 timeframe.

General risks related to forward-looking statements, market uncertainties, regulatory pressures, and feedstock fluctuations, as outlined in the SEC filings.

Q: Can you give more detail on growth plans since last update?

A: Discussed Thailand, Antwerp, and Gen 2 facilities, including Thailand's exclusivity with Procter & Gamble in Southeast Asia.

Q: Granularity on the 17 post-trial applications?

A: Tech works, customers in late-stage discussions, working through supply chain logistics.

Q: Commercialization and picking customers?

A: Focus on decommoditized specialty product, maximizing margin across segments, in-house compounding for customer needs.

Q: Customer diversification and Gen 2 scaling?

A: Selective with fast-moving customers, focus on segments with margin, Gen 2 leveraging Ironton learnings for reliability.

Q: 2H ramp and EBITDA breakeven?

A: Q3 and Q4 ramp, Q3 revenue target, corporate breakeven on track.

Q: Feedstock and circularity?

A: PureCycle's product differentiates, feedstock plus pricing model, circularity as opportunity for lower feedstock cost.

Q: Narrowing market focus?

A: Efficient funnel progression, broad stroke at Ironton to build pipeline demand.